Novel drug prevents common viral disease in stem-cell transplant patients, study finds

A new drug can often prevent a common, sometimes severe viral disease in patients receiving a transplant of donated blood-making stem cells, a clinical trial led by researchers at Dana-Farber Cancer Institute and Brigham and Women's Hospital indicates.

http://medicalxpress.com/news/2013-09-drug-common-viral-disease-stem-cell.html